Identification of anaplastic lymphoma kinase fusions in renal cancer

Comprehensive Histologic Analysis of ALK-Rearranged Lung Carcinomas

(2011) Akihiko Yoshida et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer

(2011) Takashi Kijima et al.   CANCER SCIENCE

Pulmonary Inflammatory Myofibroblastic Tumor Expressing a Novel Fusion, PPFIBP1-ALK: Reappraisal of Anti-ALK Immunohistochemistry as a Tool for Novel ALK Fusion Identification

(2011) K. Takeuchi et al.   CLINICAL CANCER RESEARCH

Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH

(2011) Eunhee S. Yi et al.   Journal of Thoracic Oncology

ALK fusion gene positive lung cancer and 3 cases treated with an inhibitor for ALK kinase activity

(2011) Hideki Kimura et al.   LUNG CANCER

Crizotinib in Anaplastic Large-Cell Lymphoma

(2011) Carlo Gambacorti-Passerini et al.   NEW ENGLAND JOURNAL OF MEDICINE

More on Crizotinib

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

EML4-ALK Fusion Gene Assessment Using Metastatic Lymph Node Samples Obtained by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

(2010) Y. Sakairi et al.   CLINICAL CANCER RESEARCH

ALK rearrangement in sickle cell trait-associated renal medullary carcinoma

(2010) Adrián Mariño-Enríquez et al.   GENES CHROMOSOMES & CANCER

Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma

(2010) K. Takeuchi et al.   HAEMATOLOGICA

Combination of morphological feature analysis and immunohistochemistry is useful for screening of EML4-ALK-positive lung adenocarcinoma

(2010) R. Jokoji et al.   JOURNAL OF CLINICAL PATHOLOGY

Treatment of Lung Cancer with an ALK Inhibitor After EML4-ALK Fusion Gene Detection Using Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

(2010) Takahiro Nakajima et al.   Journal of Thoracic Oncology

Renal cell carcinoma with novel VCL–ALK fusion: new representative of ALK-associated tumor spectrum

(2010) Larisa V Debelenko et al.   MODERN PATHOLOGY

Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor

(2010) James E. Butrynski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

(2010) Eunice L. Kwak et al.   NEW ENGLAND JOURNAL OF MEDICINE

Xp11 translocation renal cell carcinoma

(2010) Hillary Ross et al.   PATHOLOGY

EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues

(2009) Maria Paola Martelli et al.   AMERICAN JOURNAL OF PATHOLOGY

KIF5B-ALK, a Novel Fusion Oncokinase Identified by an Immunohistochemistry-based Diagnostic System for ALK-positive Lung Cancer

(2009) K. Takeuchi et al.   CLINICAL CANCER RESEARCH

Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population

(2009) S. J. Rodig et al.   CLINICAL CANCER RESEARCH

The EML4-ALK transcript but not the fusion protein can be expressed in reactive and neoplastic lymphoid tissues

(2009) G. Sozzi et al.   HAEMATOLOGICA

2009 update on the classification of renal epithelial tumors in adults

(2009) Antonio Lopez-Beltran et al.   INTERNATIONAL JOURNAL OF UROLOGY

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology and young onset

(2009) Kentaro Inamura et al.   MODERN PATHOLOGY

Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non-Small Cell Lung Cancers

(2009) E. Lin et al.   MOLECULAR CANCER RESEARCH

EML4–ALK fusion transcript is not found in gastrointestinal and breast cancers

(2008) Y Fukuyoshi et al.   BRITISH JOURNAL OF CANCER

Multiplex Reverse Transcription-PCR Screening for EML4-ALK Fusion Transcripts

(2008) K. Takeuchi et al.   CLINICAL CANCER RESEARCH

EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers

(2008) Kentaro Inamura et al.   Journal of Thoracic Oncology

A mouse model for EML4-ALK-positive lung cancer

(2008) M. Soda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA